Maricann Looks To Replicate Canada Success In Newly Legal German Cannabis Market

Anyone looking for a model company in the medical cannabis sector would be well advised to consider Maricann Group Inc (CSE:MARI), as thus far it seems to have done everything right.

With a green ethos that drives both product development and corporate efficiency efforts, Maricann succeeded in becoming one of the first companies in Canada approved to cultivate and sell medical cannabis.

Not content with being an early mover in just its home market, Maricann was quick to stake its claim in another jurisdiction largely overlooked by its peers: Germany.

Jessica Wong
Maricann CEO Talks C$42.5M Financing Round And German Expansion: 'We Are In A Pole Position'

Javier Hasse, Benzinga, June 14, 2017

Last month, Maricann Group Inc. (CSE:MARI), a vertically integrated medical marijuana producer and distributor, announced it had secured C$42.5 million, or $32.2 million, in non-dilutive financing to increase production in Germany.

This raise was one of the biggest of 2017 and Benzinga reached out to the company’s CEO Ben Ward to chat about the business and the recent developments.

Linda Burlison
Luke, Geysens High on Maricann Expansion

Norfolk County Mayor Charlie Luke and Coun. Roger Geysens are high on Maricann Group Inc.’s multi million-dollar Langton-area expansion.“It’s phenomenal what they are doing,” said Geysens at the tail end of Tuesday evening’s in-committee meeting. “I think as things go forward, we’ll have the largest one in Canada.”

Graham Sorkin
Maricann Expanding into German Medical Cannabis Market

Maricann Group Inc., a low cost, greenhouse producer of medical cannabis with market leading technological differentiation, has established a new subsidiary in Germany called Maricann GmbH, a company that is duly incorporated with offices located in the city of Munich.

Graham Sorkin
Which Top Marijuana Company Will Capture Germany?

The German government finally passed its legalization framework for medical cannabis consumption in March 2017. The country’s market is expected to record modest growth with its high 82 million population and a policy that allows prescriptions to be paid through health insurance plans, thus potentially encouraging patients to explore medical cannabis health benefits.

Graham Sorkin
Maricann Group Begins Trading Today on the CSE

"We have been building a very strong foundation to all aspects of our business over the last four years. Now, as a public company, we continue to build on that foundation in capitalizing on growth opportunities across the expanding cannabis industry."

Graham Sorkin
Early Warning Report Issued Pursuant to National Instrument 62-103 Acquisition of Shares of Maricann Group Inc.

As a result of the completion of a reverse takeover transaction on April 20, 2017, whereby Danbel Ventures Inc. ("Danbel") acquired all the issued and outstanding securities of Maricann Inc. ("Maricann") by way of a three cornered amalgamation of Maricann and Ontario Inc., a wholly-owned subsidiary of Danbel, and the shareholders of the amalgamated company received shares of Danbel...

Graham Sorkin